Holen Sie sich die Stockscreener-App
23.03
0.73%
-0.17
Handel nachbörslich:
22.44
-0.59
-2.56%
Schlusskurs vom Vortag:
$23.20
Offen:
$23.23
24-Stunden-Volumen:
1.65M
Relative Volume:
1.01
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
36.56
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+3.00%
1M Leistung:
+4.26%
6M Leistung:
+5.64%
1J Leistung:
-40.44%
1-Tages-Spanne:
$22.75
$23.55
1-Wochen-Bereich:
$22.21
$24.29
52-Wochen-Spanne:
$13.39
$40.89
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.03 | 1.96B | 1.13B | 62.75M | 170.92M | 0.63 |
|
VEEV
Veeva Systems Inc
|
226.11 | 36.71B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.51 | 13.61B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
76.28 | 13.18B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
69.57 | 10.95B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
109.43 | 9.48B | 1.15B | 96.70M | -161.99M | 1.09 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
172,732 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Acuitas Investments LLC - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Position Lifted by Baillie Gifford & Co. - MarketBeat
Jefferies lifts Progyny stock price target to $28 on positive outlook - Investing.com India
Jefferies lifts Progyny stock price target to $28 on positive outlook By Investing.com - Investing.com South Africa
Progyny price target raised to $30 from $25 at BofA - Yahoo Finance
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Progyny Insiders Placed Bullish Bets Worth US$5.24m - Simply Wall St
Progyny (PGNY) Projected to Post Earnings on Tuesday - MarketBeat
KeyBanc maintains Progyny stock Sector Weight rating - Investing.com India
Kornitzer Capital Management Inc. KS Sells 464,570 Shares of Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Progyny, Inc. (PGNY) And Encourages Shareholders to Connect - ACCESS Newswire
Progyny stock rises on expanded IVF access By Investing.com - Investing.com Nigeria
Progyny stock rises on expanded IVF access - Investing.com India
Is Progyny, Inc.'s (NASDAQ:PGNY) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Progyny, Inc. (PGNY) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PGNYProgyny, Inc. Latest Stock News & Market Updates - StockTitan
Progyny (NASDAQ:PGNY) Price Target Raised to $25.00 at Bank of America - MarketBeat
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report - GlobeNewswire
Progyny, Inc. Announces Date for Financial Results Reporting and Conference Call for Q4 and Full Year 2024 - Nasdaq
Earnings Alert: Progyny Sets Date for 2024 Annual ResultsKey Details for Investors - StockTitan
Breaking Down Progyny: 4 Analysts Share Their Views - Benzinga
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm - EIN News
Vanderbilt University Purchases Shares of 14,730 Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
22,001 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Guidance Capital Inc. - MarketBeat
Janney Montgomery Scott LLC Takes Position in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
The Play On Progyny: Don't Chase, But Watch And Wait (NASDAQ:PGNY) - Seeking Alpha
Truist Securities Adjusts Progyny Price Target to $24 From $19, Maintains Hold Rating - Marketscreener.com
All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy - MSN
SG Americas Securities LLC Has $597,000 Stake in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
(PGNY) Proactive Strategies - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Progyny, Inc. (PGNY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Progyny, Inc. (NASDAQ:PGNY) Receives $25.50 Consensus Price Target from Brokerages - MarketBeat
Pacer Advisors Inc. Boosts Stock Holdings in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny (NASDAQ:PGNY) Price Target Raised to $23.00 at JPMorgan Chase & Co. - MarketBeat
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? - MSN
BenefitBump acquired by Progyny - The Business Journals
Progyny expands family support with BenefitBump acquisition - MSN
Progyny announces acquisition of BenefitBump, terms not disclosed - Yahoo Finance
St. Louis family benefits startup acquired by public company - The Business Journals
Progyny Acquires Parental Leave Benefits Manager BenefitBump; Shares Rise -January 28, 2025 at 10:25 am EST - Marketscreener.com
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.71%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):